<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03731611</url>
  </required_header>
  <id_info>
    <org_study_id>MS/17.07.44</org_study_id>
    <nct_id>NCT03731611</nct_id>
  </id_info>
  <brief_title>Impact of Umbilical Cord Milking in Preterm Neonates With Placental Insufficiency</brief_title>
  <official_title>Impact of Umbilical Cord Milking in Preterm Neonates With Placental Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University Children Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University Children Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effect of umbilical cord milking (UCM) on peripheral hematologic&#xD;
      parameters including hematopoietic progenitor cells in premature infants ≤ 34 weeks&#xD;
      gestational age with placental insufficiency. We hypothesize that UCM would enhance&#xD;
      peripheral CD34 concentration, hemoglobin and reduce prematurity complications like NEC and&#xD;
      IVH in preterm infant ≤ 34 week gestational age with placental insufficiency.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A pilot prospective randomized controlled study will be conducted among 3 groups, all of them&#xD;
      are preterm less than 34 weeks gestational age, in the first group umbilical cord milking&#xD;
      will be done for preterm infant with placental insufficiency. Two control groups are present,&#xD;
      in the first one umbilical cord milking will be done for preterm infants without placental&#xD;
      insufficiency (Insufficiency vs. no insufficiency), another group of immediate cord clamping&#xD;
      for preterm infants with placental insufficiency will be added (milking vs. no milking), 30&#xD;
      cases will be recruited in each group.&#xD;
&#xD;
      Umbilical cord milking (UCM) is typically performed by placing the infant below the level of&#xD;
      the placenta. The cord is held at 20-25 cm distance from the baby and milked vigorously&#xD;
      towards the umbilicus for 3 times at a speed of 10 cm/sec. After completion, the cord is&#xD;
      clamped, and the neonate is handed to the resuscitation team.&#xD;
&#xD;
      One milliliter of fetal blood will be taken from peripheral venous blood in the first 30 min&#xD;
      of life and CD34 will be assessed by flow cytometry. Secondary outcomes will be documented&#xD;
      during NICU stay that include admission CBC, peak bilirubin concentrations, CBC after 2&#xD;
      months, neonatal morbidity such as sepsis, bronchopulmonary dysplasia, necrotizing&#xD;
      enterocolitis, retinopathy of prematurity and polycythemia, therapeutic interventions such as&#xD;
      need for inotropes, nasal CPAP, mechanical ventilation and phototherapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">March 30, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peripheral venous CD34 at admission</measure>
    <time_frame>first 24 hours of infants' life</time_frame>
    <description>One milliliter of fetal blood will be taken from peripheral venous blood in the first 30 min of life and CD34 will be assessed by flow cytometry.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Admission hemoglobin</measure>
    <time_frame>first 24 hours of infants' life</time_frame>
    <description>One milliliter of neonatal blood will be taken from peripheral venous blood in the first 24 hours of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin at 2 months</measure>
    <time_frame>2 months after umbilical cord milking</time_frame>
    <description>One milliliter of neonatal blood will be taken from peripheral venous blood at 2 months of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Admission platelets</measure>
    <time_frame>first 24 hours of infants' life</time_frame>
    <description>One milliliter of neonatal blood will be taken from peripheral venous blood in the first 24 hours of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Admission WBCs</measure>
    <time_frame>first 24 hours of infants' life</time_frame>
    <description>One milliliter of neonatal blood will be taken from peripheral venous blood in the first 24 hours of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phototherapy requirements</measure>
    <time_frame>first 28 days of life</time_frame>
    <description>Need to start phototherapy for hyperbilirubinemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polycythemia</measure>
    <time_frame>first 28 days of life</time_frame>
    <description>arterial Hematocrit value more than 70%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Culture proven sepsis</measure>
    <time_frame>first 28 days of life</time_frame>
    <description>Sepsis confirmed by positive blood culture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necrotizing enterocolitis</measure>
    <time_frame>first 28 days of life</time_frame>
    <description>Necrotizing enterocolitis (Any Bell's stage)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraventricular hemorrhage</measure>
    <time_frame>first 28 days of life</time_frame>
    <description>Intraventricular hemorrhage of all grades</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bronchopulmonary dysplasia</measure>
    <time_frame>first 70 days of life</time_frame>
    <description>Oxygen requirement at 36 weeks corrected gestational age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for packed RBCs transfusion</measure>
    <time_frame>first 28 days of life</time_frame>
    <description>number of packed RBCs transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinopathy of prematurity</measure>
    <time_frame>first 28 days of life</time_frame>
    <description>Prethreshold and threshold diseases Retinopathy of prematurity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for inotropes</measure>
    <time_frame>first 28 days of life</time_frame>
    <description>Hypotension requiring inotropic support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for nasal CPAP</measure>
    <time_frame>first 28 days of life</time_frame>
    <description>respiratory distress requiring CPAP support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for mechanical ventilation</measure>
    <time_frame>first 28 days of life</time_frame>
    <description>respiratory distress requiring mechanical ventilation support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of oxygen therapy</measure>
    <time_frame>first 70 days of life</time_frame>
    <description>Duration of oxygen therapy</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Placental Insufficiency</condition>
  <condition>Preterm Infant</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>umbilical cord milking will be done for preterm infants &lt;34 gestational age without placental insufficiency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>umbilical cord milking will be done for preterm infant &lt;34 gestational age with placental insufficiency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Immediate cord clamping for preterm infants &lt;34 gestational age with placental insufficiency</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Umbilical Cord Milking</intervention_name>
    <description>Umbilical cord milking (UCM) is typically performed by placing the infant below the level of the placenta. The cord is held at 20-25 cm distance from the baby and milked vigorously towards the umbilicus for 3 times at a speed of 10 cm/sec. After completion, the cord is clamped, and the neonate is handed to the resuscitation team.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  preterm neonates &lt; 34 weeks gestational age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Vaginal bleeding due to placental abruption or tears&#xD;
&#xD;
          -  Multiple pregnancies&#xD;
&#xD;
          -  Suspected major fetal anomalies&#xD;
&#xD;
          -  Suspected chromosomal aberration&#xD;
&#xD;
          -  Maternal drug abuse&#xD;
&#xD;
          -  Hydrops fetalis&#xD;
&#xD;
          -  preterm who needed major resuscitative measures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mansoura University Children Hospital</name>
      <address>
        <city>Mansourah</city>
        <state>El Dakahlya</state>
        <zip>35111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mansoura University Children's Hospital</name>
      <address>
        <city>Mansourah</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <results_reference>
    <citation>Li J, Yu B, Wang W, Luo D, Dai QL, Gan XQ. Does intact umbilical cord milking increase infection rates in preterm infants with premature prolonged rupture of membranes? J Matern Fetal Neonatal Med. 2020 Jan;33(2):184-190. doi: 10.1080/14767058.2018.1487947. Epub 2018 Sep 6.</citation>
    <PMID>29886779</PMID>
  </results_reference>
  <results_reference>
    <citation>Kumar B, Upadhyay A, Gothwal S, Jaiswal V, Joshi P, Dubey K. Umbilical Cord Milking and Hematological Parameters in Moderate to Late Preterm Neonates: A Randomized Controlled Trial. Indian Pediatr. 2015 Sep;52(9):753-7.</citation>
    <PMID>26519708</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 3, 2018</study_first_submitted>
  <study_first_submitted_qc>November 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2018</study_first_posted>
  <last_update_submitted>March 12, 2021</last_update_submitted>
  <last_update_submitted_qc>March 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University Children Hospital</investigator_affiliation>
    <investigator_full_name>Nehad Nasef</investigator_full_name>
    <investigator_title>Professor of pediatrics/Neonatology</investigator_title>
  </responsible_party>
  <keyword>Umbilical cord milking</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Placental Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

